Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis
Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · 2026 · 65 (1) · 10-18
DOI: 10.7248/jjrhi.65.10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 2026. Verfasst von Keigo Nakaachi und 6 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nakaachi, K., Matsune, S., Usukura, N., Hosoya, K., Komachi, T., Okubo, K., & Gotoh, M. (2026). Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology), 65(1), 10-18. https://doi.org/10.7248/jjrhi.65.10
Vancouver
Nakaachi K, Matsune S, Usukura N, Hosoya K, Komachi T, Okubo K, et al. Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis. Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology). 2026;65(1):10-18. doi:10.7248/jjrhi.65.10
BibTeX
@article{Nakaachi2026,
author = {Nakaachi, Keigo and Matsune, Shoji and Usukura, Norihiro and Hosoya, Kei and Komachi, Taro and Okubo, Kimihiro and Gotoh, Minoru},
title = {Use of Vascular Endothelial Growth Factor as a Biomarker for Therapeutic Response to Dupilumab in Eosinophilic Chronic Rhinosinusitis},
journal = {Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)},
year = {2026},
volume = {65},
number = {1},
pages = {10--18},
doi = {10.7248/jjrhi.65.10}
}
EUVIMED